Correction: Mol Biomed 4, 34 (2023)
https://doi.org/10.1186/s43556-023-00145-z
Following publication of the original article [1], the authors reported that a funding number needed to be added in the funding section.
The original version is:
This research was supported by the Open project of the Key Laboratory of Hydatid Disease of Ningxia Medical University, the Key Scientific and Technological Project of Henan Province (Grant No. 222102310025), the Project for Young Scientists of Henan Province, the International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan (Grant No. KFKTYB202210), and the 111 Project (Grant No. D20036).
The updated version is:
This research was supported by the Open project of the Key Laboratory of Hydatid Disease of Ningxia Medical University, the Key Scientific and Technological Project of Henan Province (Grant No. 222102310025), the Project for Young Scientists of Henan Province (Grant No. 225200810074), the International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan (Grant No. KFKTYB202210), and the 111 Project (Grant No. D20036).
The original article [1] has been corrected.
Reference
1. Yang, S; Duan, L; Wang, C et al. Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses. Mol Biomed; 2023; 4, 34. [DOI: https://dx.doi.org/10.1186/s43556-023-00145-z] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37853288][PubMedCentral: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584785][COI: 1:CAS:528:DC%2BB3sXitFyksbzO]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
1 Ningxia Medical University, School of Basic Medical Science, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803); Key Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803); Ningxia Medical University, Center of Scientific Technology, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803)
2 Henan Key Laboratory of Immunology and Targeted Drugs, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X); Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X)
3 Ningxia Medical University, School of Basic Medical Science, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803); Key Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803)
4 Key Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803); Ningxia Medical University, Center of Scientific Technology, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803)
5 Ningxia Medical University, School of Basic Medical Science, Yinchuan, People’s Republic of China (GRID:grid.412194.b) (ISNI:0000 0004 1761 9803)